Elbow Joint Injection

Evidence at a Glance

The elbow is an intermediate joint, so a true intra-articular elbow injection - and an olecranon bursa injection - is reported with 20605/20606, not the major-joint codes. The critical distinction, however, is that the most common elbow injection is not a joint injection at all: lateral and medial epicondylitis (tennis and golfer's elbow) are tendon injections, reported with 20550 or 20551, because the epicondyle is a tendon origin outside the joint capsule. Defaulting an epicondylitis injection to a joint code is the signature elbow coding error. Hyaluronic acid is not covered for the elbow.

Domain	Summary
Medicare NCD	No national coverage determination specific to elbow injection. Corticosteroid/anesthetic injection is broadly covered when medically necessary.
Medicare LCD / Article	MAC joint- and tendon-injection policies set diagnosis and frequency parameters. Hyaluronan coverage is knee-only; elbow viscosupplementation is not covered.
Commercial Coverage	Corticosteroid injection covered as medically necessary for qualifying elbow pathology refractory to conservative care. Elbow hyaluronic acid is non-covered.
Evidence Level	Corticosteroid provides short-term relief in epicondylitis and olecranon bursitis, though epicondylitis is a degenerative tendinopathy with limited long-term corticosteroid benefit; guidance improves accuracy.
Image Guidance	Optional. Landmark injection is common. Ultrasound is bundled into 20606 for joint/bursa; for tendon injections (20550/20551), ultrasound is reported separately (76942) with a retained image.
Prior Authorization	Corticosteroid injection usually not prior-authorized. Verify plan-specific rules; elbow hyaluronic acid is denied regardless.
Conservative Therapy	Document activity modification, bracing, physical/occupational therapy, and analgesics/NSAIDs before injection to support medical necessity.
Diagnostic Block	Not typically required. An anesthetic component can localize the pain source within the same encounter.
Key Documentation	The specific target (elbow joint / olecranon bursa / tendon origin), laterality, guidance modality, injectate and units, and pre-/post pain scores.
Approval Considerations	Target-correct code (intermediate joint vs tendon), laterality-specific diagnosis, correct guidance reporting, and documented conservative care.

Procedure Overview

Elbow injections deliver corticosteroid and/or anesthetic to one of several targets: the elbow joint for osteoarthritis or inflammatory arthropathy, the olecranon bursa for bursitis, or the common extensor or flexor-pronator tendon origin for lateral or medial epicondylitis. The elbow joint and olecranon bursa are intermediate structures; the tendon origins are outside the joint entirely. Each target is generally accessible by landmark technique, with ultrasound used selectively to confirm placement, particularly for tendon injections.

The operational crux is that the target determines not only the code but the code family. A joint or bursa injection is an arthrocentesis-family service (20605/20606); an epicondylitis injection is a tendon-family service (20550/20551). These are billed and guided differently, and the record must specify the exact structure so the coder does not default an epicondylitis injection into an intermediate-joint code - the most frequent elbow billing error.

Relevant Anatomy (High-Level)

The relevant structures are the elbow (humeroulnar and radiocapitellar) joint, the olecranon bursa overlying the olecranon process, the common extensor tendon origin at the lateral epicondyle (lateral epicondylitis), and the common flexor-pronator origin at the medial epicondyle (medial epicondylitis). The key anatomic fact for coding is that the epicondyles are tendon origins external to the joint capsule: an injection there is a tendon injection, not a joint or bursa injection. Contemporary understanding recognizes epicondylitis as a degenerative tendinopathy rather than a purely inflammatory process, which tempers expectations for corticosteroid durability.

Clinical Indications

Lateral epicondylitis (tennis elbow) at the common extensor origin.
Medial epicondylitis (golfer's elbow) at the common flexor-pronator origin.
Olecranon bursitis with symptomatic effusion or inflammation.
Elbow osteoarthritis or inflammatory arthropathy with intra-articular pain, or symptomatic effusion requiring aspiration.
Symptoms persisting despite documented conservative care.

Patient Selection

Selection depends on localizing the pain generator so the correct target is injected and coded:

Examination localizing pain to a specific structure (tendon origin, joint, or bursa) with corroborating provocative tests.
A documented trial of, or contraindication to, conservative management, including bracing and therapy for epicondylitis.
Functional impairment the injection is intended to improve (grip, lifting, activities of daily living).
For epicondylitis, a candid discussion that corticosteroid provides short-term relief in a degenerative tendinopathy.
Aspiration considered where a tense olecranon bursa effusion is present.

Contraindications

Absolute	Relative
Overlying infection; suspected septic joint or bursa.	Therapeutic anticoagulation or coagulopathy (individualized).
Known allergy to the planned injectate.	Poorly controlled diabetes (corticosteroid glycemic effect).
Patient refusal or inability to cooperate.	Superficial tendon/subcutaneous location (skin atrophy, depigmentation risk).

Repeated recent corticosteroid injection at the same site (cumulative risk).

Medical Necessity

Medical necessity is established by documenting the pain generator, the failure of conservative care, and the therapeutic goal. Payers expect:

The specific target and a diagnosis consistent with it (for example lateral epicondylitis for a tendon-origin injection).
Laterality of the affected elbow.
A documented conservative-care trial and outcome, or a contraindication.
The functional deficit treated and the therapeutic goal.
The guidance modality and rationale where guidance is used.

Medicare Coverage Guidance

No National Coverage Determination is specific to elbow injection. Coverage principles:

Corticosteroid / anesthetic injection. Covered when medically necessary under MAC joint- and tendon-injection policy, with diagnosis and frequency parameters.
Target-based coding. Elbow joint and olecranon bursa are intermediate (20605/20606); epicondylitis injections are tendon injections (20550/20551).
Single unit per structure. Report one unit per joint or bursa per encounter, even if aspiration and injection are both performed.
Image guidance. Ultrasound is bundled into 20606 for joint/bursa; for tendon injections, ultrasound guidance is reported separately with 76942 (retained image required). Fluoroscopy is reported with 77002 where used.
Bilateral rules. Tendon-injection codes 20550/20551 are not subject to bilateral (modifier 50) reporting; use RT/LT to identify the side.
Hyaluronic acid. Not covered for the elbow; hyaluronan coverage is knee-only.

Commercial Payer Comparison

Payer / Program	Typical Posture on Elbow Injection
eviCore / Carelon / Cohere / Evolent	Corticosteroid joint, bursa, and tendon injections generally not managed by interventional-pain UM programs; verify any musculoskeletal-management delegation.
Cigna	Covered for qualifying elbow pathology refractory to conservative care; viscosupplementation policies restrict coverage to the knee.
Aetna	Considers corticosteroid elbow injection medically necessary for documented pathology; regenerative injectates for epicondylitis are frequently considered experimental.
UnitedHealthcare	Covers corticosteroid injection under medical policy; its hyaluronic-acid drug policy limits coverage to the knee.
Humana	Medicare Advantage aligns with CMS/MAC principles; commercial follows medical-necessity criteria with frequency edits.
Blue Cross Blue Shield plans	Plan-specific policies; corticosteroid injection covered for qualifying pathology; elbow viscosupplementation non-covered. Verify the local licensee policy.

Documentation Requirements

Specific target (elbow joint / olecranon bursa / tendon origin / sheath).
Laterality (right / left) documented.
Diagnosis consistent with the target injected.
Conservative therapy history and outcome.
Guidance modality (landmark / ultrasound / fluoroscopy).
For ultrasound with a tendon injection: retained image for 76942.
Injectate name, concentration, and units.
Pre-injection numeric pain score.
Post-injection pain score and immediate percent relief.
Functional impairment and therapeutic goal.
Correct code family (intermediate joint / bursa vs tendon).
Signed and dated procedure note.

Imaging Requirements

Diagnostic imaging (radiographs, ultrasound, or MRI) supports the diagnosis and excludes competing pathology, and ultrasound is particularly useful for characterizing tendinopathy and bursal effusion. Procedural guidance is optional for the elbow because targets are accessible by landmark technique. The coding of guidance depends on the target: for a joint or bursa injection, ultrasound guidance is bundled into 20606; for a tendon injection (20550/20551), ultrasound guidance is reported separately with 76942 when a permanent image is retained. Fluoroscopy is reported with 77002 where used. Document the modality and rationale.

Prior Authorization Workflow

Benefit verification. Confirm coverage for corticosteroid injection and any guidance; confirm elbow hyaluronic acid and regenerative injectates are non-covered before offering them.
Target identification. Determine and document the specific structure to be injected before the encounter where possible.
Diagnosis validation. Confirm a laterality-specific diagnosis consistent with the target.
Conservative-care confirmation. Verify the documented trial satisfies the payer's expectation.
Guidance decision. Map the modality to the correct reporting (bundled 20606 for joint/bursa; separate 76942 for tendon injections).
Procedure and coding. Report one unit per structure with laterality; do not append modifier 50 to 20550/20551.
Post-service integrity. Ensure target, laterality, guidance, and pre-/post pain scores are recorded.

Common Prior Authorization & Claim Denials

Denial Reason	Root Cause / Prevention
Epicondylitis coded as a joint injection	20605 billed for a tendon-origin injection. Report 20550/20551 for epicondylitis; the epicondyle is outside the joint.
Target not documented	Note says only "elbow injection." Document the specific structure so the correct code family applies.
Guidance mis-reported	76942 added to a joint injection (bundled in 20606), or omitted for a tendon injection where used. Map guidance to the target.
Elbow hyaluronic acid / regenerative injectate billed	Non-covered injectate reported. Do not bill elbow HA or investigational regenerative products expecting coverage.
Modifier 50 on tendon injection	Bilateral modifier appended to 20550/20551, which is not bilateral-eligible. Use RT/LT.
Unspecified laterality / diagnosis mismatch	Diagnosis not laterality-specific or inconsistent with the target. Code laterality and match diagnosis to target.
Multiple units for one structure	More than one unit for the same joint/bursa. Report a single unit per structure.
Missing pre/post assessment	Record lacks documented pain scores. Capture pre-/post scores and percent relief.

Appeal Strategies

Submit the procedure note documenting the specific target, laterality, guidance modality, injectate and units, and pre-/post pain scores.
For epicondylitis denials, confirm the tendon-injection code (20550/20551) and resubmit if a joint code was used in error.
For guidance denials, supply the retained ultrasound image (for 76942) and the rationale.
For conservative-care denials, attach the documented therapy trial and outcome.
For diagnosis denials, correct to a laterality-specific code consistent with the target.
Do not appeal elbow hyaluronic-acid or investigational-injectate denials on medical-necessity grounds; the non-coverage is categorical.

Coding & Billing Overview

Applicable CPT® Codes by Target

CPT®	Descriptor / Target	Application
20605 / 20606	Intermediate joint or bursa (without / with ultrasound)	Elbow joint; olecranon bursa.
20551	Injection(s); single tendon origin/insertion	Epicondylitis at the tendon origin (anatomically the common choice).
20550	Injection(s); single tendon sheath, ligament, aponeurosis	Per CPT® elbow-section notation, used for tennis elbow; also tendon sheath.
76942 / 77002	Ultrasound / fluoroscopic guidance (with tendon injections)	Reported separately with 20550/20551 when guidance is used and documented.

HCPCS (Injectate)

Corticosteroid is reported with the appropriate J-code (for example J1030 methylprednisolone acetate 40 mg, or J3301 triamcinolone acetonide per 10 mg) on the same claim. Local anesthetics are frequently not separately payable. Hyaluronic acid supply codes apply to the knee only and should not be reported for the elbow.

Common ICD-10-CM Diagnosis Codes

Code	Description	Typical Target
M77.11 / M77.12	Lateral epicondylitis, right / left elbow	Extensor tendon origin.
M77.01 / M77.02	Medial epicondylitis, right / left elbow	Flexor-pronator origin.
M70.21 / M70.22	Olecranon bursitis, right / left elbow	Olecranon bursa.
M19.021 / M19.022	Primary osteoarthritis, right / left elbow	Elbow joint.
M25.521 / M25.522	Pain in right / left elbow	When specific diagnosis not established.

Modifiers, POS & ASC

Element	Guidance
Modifier RT / LT	Identify the elbow; required for tendon injections that are not bilateral-eligible.
Modifier 50	May apply to 20605/20606 per payer for bilateral joint/bursa; not used with 20550/20551.
Modifier 59 / X{EPSU}	For a genuinely distinct additional structure; document distinctness.
Modifier 25	For a significant, separately identifiable E/M on the same day.
Place of Service	POS 11 (office) typical; POS 22 or 24 where applicable.
ASC considerations	Predominantly office-based; ASC use is uncommon.

Clinical Documentation Checklist

Specific target documented.
Laterality (RT / LT).
Diagnosis matched to target.
Conservative therapy trial and outcome.
Guidance modality and (for tendon injection) image retained.
Injectate name, concentration, units.

Pre-injection numeric pain score.
Post-injection pain score and percent relief.
Correct code family (intermediate joint/bursa vs tendon).
No modifier 50 on tendon injections.
No elbow hyaluronic acid or investigational injectate billed.
Functional goal documented.

Procedure Comparison

Target	Typical CPT®	Common Diagnosis	Notes
Elbow joint	20605 / 20606	M19.02-	Intermediate joint - not 20610.
Olecranon bursa	20605 / 20606	M70.2-	Intermediate bursa; named in descriptor.
Lateral epicondyle	20551 (or 20550)	M77.1-	Tendon origin; not a joint injection.
Medial epicondyle	20551 (or 20550)	M77.0-	Tendon origin; not a joint injection.

GoHealthcare Clinical Insights

Separate the joint from the tendon at the point of documentation. The defining elbow error is coding an epicondylitis (tendon) injection as an intermediate-joint injection. A note template that forces selection of joint, bursa, or tendon origin prevents this at the source. Know the guidance rule differs by target. Ultrasound is bundled into the joint/bursa code (20606) but reported separately (76942) for tendon injections. Coders must apply the right rule for the structure injected. Set realistic epicondylitis expectations. Because tennis and golfer's elbow are degenerative tendinopathies, corticosteroid offers short-term relief; documenting this supports a staged plan and avoids repeat-injection patterns that draw scrutiny.

GoHealthcare Leadership Perspective

The elbow reinforces a theme running through this series: the injected structure, not the body region, determines the code family. At the elbow the stakes are higher because the most common injection - epicondylitis - sits outside the joint entirely and is easily mis-coded into an arthrocentesis code. The leadership priorities are a note template that forces target selection (joint, bursa, or tendon origin), a coding rule that routes epicondylitis to the tendon codes and applies the correct guidance reporting, and a categorical block on non-covered injectates. These convert an error-prone service into a precise, defensible one, and prevent the tendon-versus-joint mis-coding that drives elbow denials.

GoHealthcare Prior Authorization Insight

The authorization insight for the elbow is that the exposure is coding precision, not authorization friction. Corticosteroid elbow injections rarely require prior authorization, but they deny for tendon-versus-joint mis-coding, guidance mis-reporting, and non-covered injectates - none of which an authorization step would catch. Our quality-assurance approach verifies target-to-code alignment, the correct guidance reporting for that target, and diagnosis-to-target consistency before the claim drops, and excludes non-covered injectates categorically. This front-loads the accuracy the payer will otherwise enforce on review.

GoHealthcare Case Study

The following case is a composite created for education. It does not depict any actual patient or organization.

Clinical Scenario

A patient with recalcitrant right lateral epicondylitis, unresponsive to bracing and therapy, underwent an ultrasound-guided corticosteroid injection at the common extensor tendon origin. The practice billed 20605 with 76942 and an unspecified elbow-pain diagnosis.

Documentation & Coding Challenges

The claim denied. The injection targeted a tendon origin, not the joint or bursa, so it should have been reported with a tendon code (20551, or 20550 per the CPT notation) rather than the intermediate-joint code 20605; the ultrasound guidance was reportable separately with 76942 for a tendon injection but had been paired with a joint code that bundles guidance; and the diagnosis was a generic elbow-pain code rather than lateral epicondylitis.

Payer & Prior Authorization Barriers

Corticosteroid injection required no prior authorization, so no checkpoint had validated the target-to-code alignment or the guidance reporting before submission.

Resolution Strategy

The practice recoded to the appropriate tendon-injection code with 76942 reported separately, corrected the diagnosis to lateral epicondylitis with laterality, and resubmitted. Prospectively, it added a target-selection field distinguishing joint, bursa, and tendon origin, and a coding rule routing epicondylitis to the tendon codes.

Outcome & Lessons Learned

The corrected claim was paid, and elbow-injection denials fell in the following quarter. The lesson: at the elbow, distinguishing the tendon from the joint at the point of documentation is the decisive control, and it operates independently of any authorization requirement.

GoHealthcare Best Practices

Require target selection (elbow joint / olecranon bursa / tendon origin / sheath) in the note template.
Route epicondylitis injections to the tendon codes (20551 or 20550 per CPT® notation), never a joint code.
Apply the correct guidance reporting: bundled in 20606 for joint/bursa; separate 76942 for tendon injections.
Match the diagnosis to the target and specify laterality.
Do not append modifier 50 to 20550/20551; use RT/LT.
Block elbow hyaluronic acid and investigational injectates at the claim-edit level.

Common Mistakes

Coding an epicondylitis (tendon) injection as an intermediate-joint injection (20605).
Coding the elbow joint or olecranon bursa as a major joint (20610).
Adding 76942 to a joint injection (guidance is bundled in 20606).
Omitting separately reportable ultrasound guidance for a tendon injection.
Appending modifier 50 to a tendon injection.
Using a generic or mismatched diagnosis for a specific target.
Billing elbow hyaluronic acid or an investigational regenerative injectate.
Omitting laterality or pre-/post pain scores.

Pearls and Pitfalls

Pearls	Pitfalls
Document whether the target is joint, bursa, or tendon origin.	Leaving the target as "elbow" and forcing a guess.
Route epicondylitis to a tendon code.	Defaulting epicondylitis to 20605.
Apply guidance reporting by target.	Adding 76942 to a bundled joint code.
Use RT/LT on tendon injections.	Appending modifier 50 to 20550/20551.
Match each diagnosis to its target.	Pairing a tendon injection with a joint diagnosis.

Frequently Asked Questions

What code is used for an intra-articular elbow injection?

20605 (without ultrasound) or 20606 (with ultrasound). The elbow is an intermediate joint, not a major joint, so 20610 is incorrect.

What code is used for an olecranon bursa injection?

20605 or 20606. The olecranon bursa is an intermediate bursa named in the descriptor.

How is a tennis-elbow (lateral epicondylitis) injection coded?

As a tendon injection. Anatomically the epicondyle is a tendon origin (20551), but CPT®'s elbow-section notation directs use of 20550 for tennis elbow. Follow the CPT® instruction and payer guidance, and document the exact structure.

Why is coding epicondylitis as 20605 wrong?

The epicondyle is a tendon origin outside the joint capsule, so an epicondylitis injection is a tendon injection (20550/20551), not a joint or bursa injection.

How is a golfer's-elbow (medial epicondylitis) injection coded?

The same way as lateral epicondylitis: a tendon injection (20551 or 20550), with the medial-epicondylitis diagnosis (M77.0-).

How do I report ultrasound guidance at the elbow?

For a joint or bursa injection, ultrasound is bundled into 20606. For a tendon injection (20550/20551), report ultrasound guidance separately with 76942 when a permanent image is retained.

Can I use modifier 50 for bilateral epicondylitis injections?

No. The tendon-injection codes 20550/20551 are not bilateral-eligible; use RT/LT for each side.

What ICD-10 codes are used?

Lateral epicondylitis M77.11/M77.12; medial epicondylitis M77.01/M77.02; olecranon bursitis M70.21/M70.22; elbow OA M19.021/M19.022 - matched to the target with laterality.

Is hyaluronic acid covered for the elbow?

No. Hyaluronic acid is covered for the knee only; elbow viscosupplementation is non-covered.

Are regenerative injectates covered for epicondylitis?

Platelet-rich plasma and similar injectates are frequently considered investigational and non-covered. Verify coverage before offering them.

How many units per structure?

One unit per joint or bursa per encounter, even if aspiration and injection are both performed.

Does the diagnosis need to match the target?

Yes. An epicondylitis diagnosis for a tendon injection; a bursitis diagnosis for the bursa; an OA diagnosis for the joint.

Does elbow injection require prior authorization?

Corticosteroid injection usually does not. Verify plan rules; non-covered injectates are denied regardless.

Is conservative care required first?

Frequently. Document a conservative-care trial (bracing, therapy, analgesics) and outcome, or a contraindication, before injection.

Can I aspirate an olecranon bursa and inject in the same session?

Yes; report a single unit of 20605/20606 for the combined aspiration and injection of that structure.

What place of service applies?

POS 11 (office) is typical; POS 22 or 24 where applicable.

How durable is corticosteroid for epicondylitis?

Relief is typically short-term, since epicondylitis is a degenerative tendinopathy; document realistic expectations and a staged plan.

Can I bill an E/M on the same day?

Only for a significant, separately identifiable evaluation beyond the injection work, with modifier 25.

What imaging supports the diagnosis?

Ultrasound characterizes tendinopathy and bursal effusion; radiographs and MRI are used selectively to exclude other pathology.

What single control most reduces elbow-injection denials?

A required target-selection field distinguishing joint, bursa, and tendon origin, with a rule routing epicondylitis to the tendon codes.

Is the sheath code (20550) ever right for the elbow?

Yes. Per the CPT® elbow-section notation it is used for tennis elbow, and it applies to tendon sheath/tenosynovitis injections; documentation of the exact structure decides between 20550 and 20551.

Why did my elbow claim deny?

Common causes are tendon-versus-joint mis-coding, guidance mis-reporting, a mismatched diagnosis, or a non-covered injectate. Correct and resubmit.

Key Takeaways

The elbow joint and olecranon bursa are intermediate (20605/20606) - not major (20610).
Epicondylitis is a tendon injection (20551, or 20550 per CPT® notation) - never a joint code.
Ultrasound is bundled into 20606 for joint/bursa but reported separately (76942) for tendon injections.
Do not append modifier 50 to 20550/20551; use RT/LT.
Match the diagnosis to the target and specify laterality; parents M77.0/M77.1/M70.2 are non-billable.
Hyaluronic acid and investigational regenerative injectates are non-covered for the elbow.
Document the exact structure on every elbow-injection note.

Future Outlook

Ultrasound will play a growing role in elbow injection, both for diagnosis and for confirming tendon-origin and bursal placement, reinforcing the need for correct, target-specific guidance reporting. The reframing of epicondylitis as a degenerative tendinopathy will continue to shape treatment toward staged rehabilitation and more selective corticosteroid use, while regenerative injectates remain investigational pending stronger evidence. Corticosteroid joint, bursa, and tendon injection will remain covered where medically necessary. Practices that enforce target-based documentation and coding now will adapt smoothly as payer edits tighten.

References

American Medical Association. CPT® 2026 Professional Edition (20550, 20551, 20605, 20606) and elbow-section notation on tennis-elbow injection. https://www.ama-assn.org/practice-management/cpt KZA. Coding Coaches - Elbow Injection (20605 joint/bursa vs 20551/20550 tendon). https://www.kzanow.com/coding-coaches/elbow-injection AAPC. Auditors: Accelerate Your Knowledge of Anatomy to Choose Between 20605 and 20551. https://www.aapc.com/blog/30150-auditors-accelerate-your-knowledge-of-anatomy-to-choose-between-codes/AAPC. Reader Questions - 20550 or 20551 for Elbow Epicondylitis Injection. https://www.aapc.com/codes/coding-newsletters/my-orthopedic-coding-alert/reader-questions-20550-or-20551-for-elbow-epicondylitis-injection-article ICD-10-CM 2026, M77.1- (Lateral epicondylitis), M77.0- (Medial epicondylitis), M70.2- (Olecranon bursitis). https://www.icd10data.com/ICD10CM/Codes/M00-M99/M70-M79 Centers for Medicare & Medicaid Services. Medicare Coverage Database (joint/tendon injection LCDs/articles; hyaluronan knee-only). https://www.cms.gov/medicare-coverage-database American Academy of Orthopaedic Surgeons (AAOS). https://www.aaos.org American Society for Surgery of the Hand (ASSH) upper-extremity resources. https://www.assh.org

Reading Recommendations

AMA CPT® guidance on joint-size codes and the tennis-elbow injection notation.
Your MAC's joint- and tendon-injection LCD/article and hyaluronan knee-only policy.
Commercial policies on regenerative injectates for epicondylitis.
AAOS and hand/upper-extremity society guidance on elbow tendinopathy.

Recommended Downloads

Elbow Injection Structured Note Template (with required target field).
Target-to-Code Quick-Reference (joint / bursa / tendon origin / sheath).
Guidance-Reporting Cheat Sheet (bundled vs separate by target).
Elbow Non-Covered-Injectate Claim-Edit Specification.

Visual Recommendations

High-level illustration of elbow injection targets (joint, olecranon bursa, medial and lateral epicondyle tendon origins).
Target-to-code decision tree (intermediate joint/bursa vs tendon).
Guidance-reporting decision flow by target.
Diagnosis-to-target matching matrix.
Coding matrix: 20605 / 20606 / 20551 / 20550 with guidance and modifiers.
Documentation checklist infographic for point-of-care use.

Educational Disclaimer

This document is intended for educational and operational reference purposes only. It does not replace physician clinical judgment, payer policy review, legal advice, or official CMS guidance, and it is not a procedural or physician training manual. Coverage policies, coding guidance, frequency limitations, and reimbursement requirements change frequently and vary by payer, plan, and jurisdiction; all codes and coverage criteria must be independently verified against the applicable payer policy and current regulatory sources before submission. CPT® is a registered trademark of the American Medical Association. GoHealthcare Practice Solutions assumes no liability for actions taken in reliance on this educational material.

This webpage does not replace physician judgment, official payer policy, legal advice, or current coding guidance. CPT® is a registered trademark of the American Medical Association.